DE69322268D1 - Stabile zusammensetzung von polypeptiden - Google Patents

Stabile zusammensetzung von polypeptiden

Info

Publication number
DE69322268D1
DE69322268D1 DE69322268T DE69322268T DE69322268D1 DE 69322268 D1 DE69322268 D1 DE 69322268D1 DE 69322268 T DE69322268 T DE 69322268T DE 69322268 T DE69322268 T DE 69322268T DE 69322268 D1 DE69322268 D1 DE 69322268D1
Authority
DE
Germany
Prior art keywords
polypeptides
stable composition
polypeptide
stabilized
dissolving
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69322268T
Other languages
English (en)
Other versions
DE69322268T2 (de
Inventor
Robert Swift
Mee Charles Du
Anne Randolph
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Millennium Pharmaceuticals Inc
Original Assignee
COR Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by COR Therapeutics Inc filed Critical COR Therapeutics Inc
Application granted granted Critical
Publication of DE69322268D1 publication Critical patent/DE69322268D1/de
Publication of DE69322268T2 publication Critical patent/DE69322268T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/75—Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07—Tetrapeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biomedical Technology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Cosmetics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
DE69322268T 1992-04-30 1993-04-27 Stabile zusammensetzung von polypeptiden Expired - Lifetime DE69322268T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US87662592A 1992-04-30 1992-04-30
PCT/US1993/003933 WO1993022335A1 (en) 1992-04-30 1993-04-27 Stable polypeptide composition

Publications (2)

Publication Number Publication Date
DE69322268D1 true DE69322268D1 (de) 1999-01-07
DE69322268T2 DE69322268T2 (de) 1999-08-05

Family

ID=25368192

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69322268T Expired - Lifetime DE69322268T2 (de) 1992-04-30 1993-04-27 Stabile zusammensetzung von polypeptiden

Country Status (12)

Country Link
EP (1) EP0639202B1 (de)
JP (1) JP3368282B2 (de)
AT (1) ATE173739T1 (de)
AU (1) AU679913B2 (de)
CA (3) CA2573307C (de)
DE (1) DE69322268T2 (de)
DK (1) DK0639202T3 (de)
ES (1) ES2124308T3 (de)
IL (1) IL105533A (de)
MX (1) MX9302509A (de)
TW (1) TW363973B (de)
WO (1) WO1993022335A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5763394A (en) * 1988-04-15 1998-06-09 Genentech, Inc. Human growth hormone aqueous formulation
US5981485A (en) * 1997-07-14 1999-11-09 Genentech, Inc. Human growth hormone aqueous formulation
SE9201073D0 (sv) † 1992-04-03 1992-04-03 Kabi Pharmacia Ab Protein formulation
TW518235B (en) * 1997-01-15 2003-01-21 Akzo Nobel Nv A gonadotropin-containing pharmaceutical composition with improved stability on prolong storage
NZ336793A (en) * 1997-01-20 2000-08-25 Japan Energy Corp Method for stabilizing peptides by adding an organic acid and then lyophilizing the peptide mixture
CN1170334C (zh) * 1998-07-27 2004-10-06 钟纺株式会社 有机电解质电池
ES2571230T3 (es) 1999-04-09 2016-05-24 Kyowa Hakko Kirin Co Ltd Procedimiento para controlar la actividad de una molécula inmunofuncional
US6946292B2 (en) 2000-10-06 2005-09-20 Kyowa Hakko Kogyo Co., Ltd. Cells producing antibody compositions with increased antibody dependent cytotoxic activity
EP1698640B2 (de) * 2003-10-01 2019-06-19 Kyowa Hakko Kirin Co., Ltd. Verfahren zur stabilisierung von antikörpern und stabilisierte antikörperzubereitung vom lösungstyp
KR20080106636A (ko) * 2007-06-04 2008-12-09 동아제약주식회사 사람 융모성 성선자극호르몬 함유 즉시 사용형 주사 용액
CN102625813A (zh) 2008-06-20 2012-08-01 诺华公司 具有降低的聚集的免疫球蛋白
EP2884996B1 (de) * 2012-08-17 2020-01-08 Intervet International B.V. Immunogene zusammensetzung von getöteten leptospira-bakterien

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4379085A (en) * 1982-05-14 1983-04-05 American National Red Cross Heat stabilization of plasma proteins
DE3942144A1 (de) * 1989-12-20 1991-06-27 Boehringer Mannheim Gmbh Stabilisierung von k1k2p pro
DE3942141A1 (de) * 1989-12-20 1991-06-27 Boehringer Mannheim Gmbh K2p pro-stabilisierung
DE3942143A1 (de) * 1989-12-20 1991-06-27 Boehringer Mannheim Gmbh T-pa pro stabilisierung

Also Published As

Publication number Publication date
AU4118293A (en) 1993-11-29
AU679913B2 (en) 1997-07-17
CA2636421C (en) 2010-06-29
MX9302509A (es) 1994-05-31
JPH07509691A (ja) 1995-10-26
CA2573307A1 (en) 1993-11-11
CA2636421A1 (en) 1993-11-11
ATE173739T1 (de) 1998-12-15
CA2573307C (en) 2011-01-04
DE69322268T2 (de) 1999-08-05
WO1993022335A1 (en) 1993-11-11
DK0639202T3 (da) 1999-08-09
EP0639202B1 (de) 1998-11-25
IL105533A (en) 1998-12-06
CA2133205A1 (en) 1993-11-11
IL105533A0 (en) 1993-08-18
EP0639202A1 (de) 1995-02-22
CA2133205C (en) 2007-04-17
ES2124308T3 (es) 1999-02-01
JP3368282B2 (ja) 2003-01-20
TW363973B (en) 1999-07-11

Similar Documents

Publication Publication Date Title
DE69322268D1 (de) Stabile zusammensetzung von polypeptiden
DE3686654D1 (de) Verfahren zur isolierung rekombinanter polypeptide in biologisch aktiver form.
DE69007975D1 (de) Fusionsprotein bestehend aus gm-csf und il-3.
DE69233188D1 (de) Hormonanaloge mit mehreren ctp-erweiterungen
DE69531314D1 (de) Verwendung von metallionen chelatoren zur stabilisierung von interferon-enthaltenden pharmazeutischen zubereitungen
DK1629849T3 (da) Farmaceutiske sammensætninger indeholdende exendiner og deres agonister
DE59008910D1 (de) Stabile injizierbare lösungen von faktor viii.
ES2113354T3 (es) Estabilizacion de somatotropinas y otras proteinas por modificacion de residuos de cisteina.
BE904831A (fr) Composition d'activateur tissulaire du plasminogene.
DK0406804T3 (da) Modificeret biologisk aktivt protein
SE9101381D0 (sv) Peptide hormone solution
ATE111483T1 (de) Biologisch wirksame moleküle.
ATE34767T1 (de) Stabilisierte waessrige enzymzusammensetzung.
SE8702520D0 (sv) Mammal intestine hormone precursor
ATE116333T1 (de) Biologisch aktive moleküle.
DE69513226D1 (de) Verwendung von Azolen als Virustötende Substanzen in Lösungen von biologisch aktiven Proteinen
ATE48616T1 (de) Analoge von hypokalzemischen polypeptiden, welche den kalziumgehalt des koerpers schonen, deren herstellung, deren verwendung als arznei und diese enthaltende zusammensetzungen.
DK661888A (da) Biologisk aktive molekyler
SE9101586L (sv) Modifierat tioredoxin och dess anvaendning
KR920019933A (ko) 소의 성장 호르몬 유리 인자의 전구체 형태 및 관련 dna화합물
DE59008693D1 (de) Gewebs-Plasminogen-Aktivator-Derivat.
TH14767EX (th) กระบวนการสำหรับแยกเอารีคอมบิแนนท์โปรตีนในรูปที่ออกฤทธิ์ทางชีววิทยาออกมาจากสารละลายที่มีโปรตีนที่ไม่ออกฤทธิ์อยู่ด้วย

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: MILLENNIUM PHARMACEUTICALS INC. (N.D.GES. D. STAAT